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1 |  INTRODUCTION
In 1993, Pope, Katz, and Hudson described a new syndrome 
called “reverse anorexia,” which was subsequently renamed 
“muscle dysmorphia” (MD; Pope, Gruber, Choi, Olivardia, & 
Phillips, 1997). These authors suggested that MD was a form of 
body dysmorphic disorder (BDD), characterized by an obses-
sive preoccupation with the size and shape of one's muscles and 
causing significant distress or impairment in daily functioning.
Currently, the American Psychiatric Association (APA, 
2013) recognizes MD as a specifier for body dysmorphic dis-
order on the obsessive–compulsive disorder spectrum in the 
Diagnostic and Statistical Manual of Mental Health Disorders, 
5th edition (DSM‐5). According to the DSM‐5, individuals 
with MD are preoccupied with the idea that their body build 
is too small or insufficiently lean or muscular, although they 
actually have a normal‐looking body or are even very muscular. 
Therefore, they perform repetitive behaviors (e.g., mirror‐check-
ing, excessive‐grooming, skin‐picking, reassurance‐seeking) 
and mental acts (e.g., comparing their appearance with that of 
others) in response to their appearance concerns.
Other DSM‐5 diagnostic criteria specify that, in this disorder, 
the appearance preoccupation: (a) should cause clinically signif-
icant distress or impairment in social, occupational, or other im-
portant areas of functioning; and (b) would not be better explained 
by concerns with body fat or weight in an individual whose symp-
toms meet the diagnostic criteria for an eating disorder.
Muscle dysmorphia is more prevalent in males, par-
ticularly those who engage in sports that emphasize in-
creased muscle mass or power gain, such as weight lifting 
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Abstract
This study is a reliability generalization meta‐analysis that reviews continuous meas-
ures used to assess muscle dysmorphia (MD): The Muscle Appearance Satisfaction 
Scale, Muscle Dysmorphic Disorder Inventory, four different versions of the 
Muscle Dysmorphia Inventory, Adonis Complex Questionnaire, and the Modified 
Dysmorphia Symptoms Questionnaire. A total of 15,156 individuals from 61 stud-
ies provided 73 reliability estimates (alpha coefficients and/or test–retest reliability 
coefficients) for this meta‐analysis. Random‐ and mixed‐effects models were ap-
plied in the statistical analyses. We present the average reliability estimates for each 
measure, moderator analysis of reliability estimates across a wide variety of study 
characteristics, and the reliability induction rate. In light of this, we make specific 
recommendations for researchers and health practitioners seeking to measure MD.
K E Y W O R D S
internal consistency reliability, meta‐analysis, muscle dysmorphia, reliability generalization, temporal 
stability reliability
[Correction added on January 10, 2020, after first online publication: “muscle dysmorphias” was changed to “muscle dysmorphia” in the title.]
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or bodybuilding (APA, 2013; Cella, Iannaccone, & Cotrufo, 
2012; Fabris, Longobardi, Prino, & Settani, 2017; Phillips et 
al., 2010; Pope, Phillips, & Olivardia, 2000). Nevertheless, 
MD symptoms have also been observed in females (Hale, 
Diehl, Weaver, & Briggs, 2013; Readdy, Cardinal, & Watkins, 
2011; Robert, Munroe‐Chandler, & Gammage, 2009; Tod, 
Edwards, & Cranswick, 2016). The average age of onset of 
MD is approximately 19–20 years old (Cafri, Olivardia, & 
Thompson, 2008; Olivardia, 2001), and its etiology is not yet 
well known.
There are different tools for assessing MD symptomatol-
ogy (Lavender, Brown, & Murray, 2017; Lopez‐Cuautle, 
Vazquez‐Arevalo, & Mancilla‐Diaz, 2016; Mitchell et al., 
2017; Sandgren & Lavallee, 2018): the Muscle Appearance 
Satisfaction Scale (MASS; Mayville, Williamson, White, 
Netemeyer, & Drab, 2002), the Muscle Dysmorphic Disorder 
Inventory (MDDI; Hildebrandt, Langenbucher, & Schlundt, 
2004), the Muscle Dysmorphic Inventory (MDI; Schlundt, 
Woodford, & Brownlee, 2000), four different versions of 
the Muscle Dysmorphia Inventory (MDI; Cubberley, 2009; 
Lantz, Rhea, & Cornelius, 2002; Rhea, Lantz, & Cornelius, 
2004; Short, 2005), the Adonis Complex Questionnaire 
(ACQ; Pope, Phillips, & Olivardia, 2002), the Muscle 
Dysmorphia Symptom Questionnaire (MDSQ; Olivardia, 
Pope, & Hudson, 2000), and the Muscle Dysmorphia Scale 
(MDS; Kaminski, McFarland, & Chapman, 2008). In this 
study, we present a reliability generalization (RG) meta‐anal-
ysis of these measurement tools.
1.1 | Measurement tools to assess 
muscle dysmorphia
The MASS (Mayville et al., 2002) is the first multi‐dimen-
sional self‐report measure developed for the assessment of 
MD symptoms. In its original English version, the test con-
sists of 19 self‐report items rated on a 7‐point Likert‐type 
scale structured around five dimensions: bodybuilding de-
pendence (five items), muscle checking (four items), sub-
stance use (four items), injury (three items), and muscle 
satisfaction (three items). The Bodybuilding Dependence 
subscale reflects excessive self‐investment in the activity of 
weight lifting, along with a compulsive tendency to exercise 
with weights. The Muscle Checking subscale reflects reas-
surance‐seeking and mirror‐checking behavior to assess the 
appearance of one's muscles. The Substance Use subscale 
describes a willingness to try steroids and other potentially 
risky means to obtain muscle mass. The Injury subscale is re-
lated to symptoms of overtraining and beliefs associated with 
unsafe weight‐lifting behavior. The Muscle Satisfaction sub-
scale is related to satisfaction with one's muscle size and defi-
nition. The authors also estimated the reliability of the scale 
across two different samples of male weight‐lifting partici-
pants (total n = 372), finding that the MASS and its subscales 
had acceptable reliability with all alpha coefficients greater 
than 0.70. They also calculated test–retest reliability through 
correlation coefficients of the test scores taken at 2‐week in-
tervals, again finding acceptable reliability, with correlation 
coefficients greater than 0.70. The MASS has been translated 
and adapted to various languages and cultures: Italy (Baiocco, 
Laghi, Cacioppo, & Mazzoni, 2012), Spain (González‐Martí, 
Bustos, Contreras, & Mayville, 2012), China (Jin et al., 
2015), United Kington and Ireland (Ryan & Morrison, 2010), 
Brazil (Silva, Souza, & Silva, 2008), Peru (Cook‐del Aguila, 
Sanchez‐Castro, Yacila, Reyes‐Bossio, & Mayta‐Tristán, 
2016), Mexico (Lopez‐Cuautle, Vázquez‐Arévalo, Ruíz‐
Martínez, & Mancilla‐Díaz, 2013), and Hungary (Babusa, 
Urbán, Czeglédi, & Túry, 2012).
1.1.1 | MDDI
The MDDI (Hildebrandt et al., 2004) is a multi‐dimensional 
self‐report measure of MD derived from the Schlundt MDI 
[unpublished manuscript] based on MD research criteria. 
Hildebrandt et al. (2004) revised the original MDI for the 
purpose of integrating questions about the functional im-
pairment characteristic of MD into the instrument. The first 
version of the MDDI was composed of 21 items rated on a 
5‐point Likert‐type scale structured around three dimensions: 
drive for size (DFS) (seven items), appearance intolerance 
(seven items), and functional impairment (seven items). The 
DFS subscale consists of questions about thoughts of being 
smaller, less muscular, and weaker than desired, or the de-
sire to increase size and strength. The appearance intolerance 
(AI) subscale consists of questions addressing negative be-
liefs about one's body and the resulting appearance anxiety or 
body exposure avoidance. Finally, the functional impairment 
(FI) subscale consists of questions about behaviors related to 
maintaining exercise routines, interference of negative emo-
tions when deviating from exercise routines, or avoidance of 
social situations because of negative feelings and preoccu-
pation with one's body. The authors estimated the construct 
validity with an exploratory factor analysis, which revealed 
a consistent three‐factor structure involving cognitions, emo-
tions, and behaviors related to body image. However, five 
items were removed due to heavy loadings on multiple fac-
tors and three items due to insufficient loadings. Again, the 
authors estimated construct validity with an exploratory fac-
tor analysis, which supported the original three‐factor solu-
tion. Therefore, the final version of the MDDI contains 13 
items rated on a 5‐point Likert‐type scale and the three afore-
mentioned subscales: DFS (five items), AI (four items), and 
FI (four items). The MDDI showed adequate convergent/di-
vergent validity (Hildebrandt et al., 2004). The MDDI was 
developed in the English language, and it has been translated 
and adapted to various languages and cultures, including 
Italy (Santarnecchi & Dèttore, 2012) and Portugal (Soler, 
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Fernandes, Oliveira‐Damasceno, & Silva‐Novaes, 2013). The 
Italian adaptation showed good internal consistency for the 
MDDI total score and the DFS and FI subscales (Cronbach's 
alpha  =  0.85, 0.80 and 0.81, respectively). However, for 
the AI subscale, the alpha coefficient was 0.45. Additional 
measures used for convergent/divergent validity reported 
adequate values: BDD Y‐BOCS (r = .83), bulimia subscale 
(EDI‐3) (r = .76), body dissatisfaction (EDI‐3) (r = .81), psy-
chological functioning (SAT‐P) (r = .71), social functioning 
(SAT‐P) (r = .75), work (SAT‐P) (r = .68), and self‐esteem 
(Basic SE) (r = .81).
1.1.2 | MDI
The MDI (Schlundt et al., 2000) is a self‐report measure 
based on MD research criteria and designed to assess distress 
and discomfort associated with fear of being too small and 
not sufficiently muscular. The MDI consists of 16 items that 
are answered on a 5‐point Likert scale ranging from 0 (never) 
to 4 (always), responses are added together, with higher 
scores representing greater preoccupation with feeling small.
The MDI (Lantz et al., 2002) is a multi‐dimensional self‐
report measure based on the conceptual model of MD identi-
fied by Lantz and Rhea (Lantz, Rhea, & Mayhew, 2001; Rhea, 
Lantz, & Trail, 1999), and it is designed for the assessment of 
behavioral and psychological characteristics associated with 
MD. The MDI consists of 40 self‐report items and six sub-
scales: body size–symmetry, physique protection, exercise 
dependence, supplement use, dietary behavior, and pharma-
cological use. Five of the six subscales are scored on a 6‐point 
Likert scale from never (1) to always (6), where a higher score 
on each subscale represents a higher risk of the characteristics 
associated with MD. For the Pharmacological Use subscale, 
the respondents are required to indicate how often they use 
various pharmacological aids, ranging from never (1) to 2 or 
more times daily (6). Rhea et al. (1999) provided psychomet-
ric support for the original MDI by performing exploratory 
principal components analysis in a sample of noncompetitive, 
recreational weight trainers (n = 156). Internal consistencies 
(Cronbach's alpha) for the respective subscales were 0.73 for 
body size–symmetry, 0.88 for dietary behavior, 0.72 for exer-
cise dependence, 0.71 for physique protection, 0.75 for sup-
plement use, and 0.53 for pharmacological use.
A short version of the MDI was developed by Rhea et 
al. (2004), made up of 27 items also structured around six 
dimensions: body size/symmetry (five items), physique pro-
tection (six items), exercise dependence (four items), sup-
plement use (four items), dietary behavior (five items), and 
pharmacological use (three items). These authors assessed 
psychometric properties of the short version of the MDI. 
Specifically, they assessed construct validity using item‐
to‐total correlations, exploratory and confirmatory factor 
analyses, and structural equation modeling with a sample 
of 151 male and female bodybuilders and weight lifters. In 
that study, all the subscales showed acceptable internal reli-
ability (Cronbach's alpha = 0.72–0.94). Convergent validity 
was determined by calculating the correlations between the 
subscales of the MDI, the bodybuilding dependence scale 
(BDS; Smith, Hale, & Collins, 1998), and the drive for thin-
ness subscale of the Eating Disorder Inventory (EDI; Garner, 
Olmstead, & Polivy, 1983), all of which were significantly 
and positively correlated with the MDI.
The MDI (Short, 2005) is a multi‐dimensional self‐report 
measure based on the etiological model proposed by Grieve 
(2007), and it assesses or evaluates the four proposed diag-
nostic criteria of MD outlined by Olivardia (2001). The orig-
inal MDI contained 67 items rated on a 6‐point Likert scale 
ranging from 1 (“strongly disagree”) to 6 (“strongly agree”). 
This author performed an exploratory factor analysis with the 
data, reducing the original 67‐item scale to a 25‐item scale. 
The MDI includes eight subscales: inadequacy (five items), 
preoccupation (four items), compulsivity (three items), mus-
cularity drive (four items), increased muscularity (two items), 
body anxiety (three items), social sacrifice subscale (two 
items), and persistence (two items). The inadequacy subscale 
provides a measure of the second criterion, Part C, of MD. 
The preoccupation subscale provides a measure of the first 
criterion. The compulsivity subscale provides a measure of 
the second criterion, Part A. The muscularity drive subscale 
provides a measure of an overall drive for muscularity. The 
increased muscularity subscale provides a measure of a de-
sire to increase muscle mass. The body anxiety subscale pro-
vides a measure of the second criterion, Part B. The social 
sacrifice subscale provides a measure of the second criterion, 
Part A. The persistence subscale provides a measure of the 
second criterion, Part D. The internal consistency of the MDI 
was estimated using Cronbach's alpha, which was 0.87 for 
the final MDI, 0.89 for inadequacy, 0.84 for preoccupation, 
0.74 for compulsivity, 0.74 for muscularity drive, 0.75 for 
increased muscularity, 0.72 for body anxiety, 0.92 for social 
sacrifice, and 0.83 for persistence (Short, 2005), showing a 
high level of reliability.
The MDI (Cubberley, 2009) consists of 34 self‐report 
items rated on a 6‐point Likert scale from 1 (“strongly dis-
agree”) to 6 (“strongly agree”). Items’ scores are added to-
gether to create a total score, with higher scores indicating 
more symptoms of MD. The MDI includes ten dimensions: 
body anxiety (three items), compulsivity (three items), il-
lusory correlations (two items), inadequacy (six items), in-
appropriate eating (four items), increased muscularity (two 
items), muscularity drive (four items), persistence (three 
items), preoccupation (four items), and social sacrifice (three 
items). This author provided evidence of the validity and reli-
ability of the MDI with a sample of 78 male college students. 
In this study, the MDI had acceptable test–retest reliability 
(r = .59), good internal consistency (Cronbach's alpha = 0.85 
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and 0.90 for total scores in time 1 and time 2, respectively), 
and good concurrent validity compared to other tests that 
measure symptoms of MD.
1.1.3 | ACQ
The ACQ (Pope et al., 2002) assesses a subject's degree of 
concern about their physical appearance and to what extent it 
can negatively influence their life, with these behaviors be-
coming pathological. It consists of 13 self‐report items rated 
on a 4‐point Likert‐type scale ranging from 0 (“rarely or not 
at all”) to 3 (“frequently”). The total score on the ACQ ranges 
from 0 to 39, with higher scores indicating higher levels of 
MD. Reliability measures have not been published for the 
original version of the ACQ. The ACQ was translated into 
Spanish by Baile (2005) and adapted to the Spanish con-
text by Latorre‐Román, Garrido‐Ruiz, and García‐Pinillos 
(2015). The Spanish version of the ACQ (Latorre‐Román et 
al., 2015) is composed of 13 items and three subscales: psy-
chosocial effect of physical appearance (six items), control 
over physical appearance (four items), and concerns about 
physical appearance (three items). The internal consistency 
of the ACQ was estimated using Cronbach's alpha, which 
was 0.88 for the final ACQ, 0.88 for the psychosocial effect 
of physical appearance, 0.75 for control over physical ap-
pearance, and 0.70 for concerns about physical appearance. 
In addition, the ACQ had acceptable test–retest reliability 
(r  =  .71) and good concurrent validity when compared to 
other tests that measure symptoms of MD.
1.1.4 | MDSQ
The MDSQ (Olivardia et al., 2000) was designed to detect 
individuals who exhibit a cognitive preoccupation with their 
degree of muscularity, anxiety about this perceived defect, 
and behaviors aimed at overcoming this defect. It is a revised 
measurement instrument that emerged from logically related 
measures of body dysmorphia (described as a pathological 
preoccupation with a specific aspect of body appearance, 
such as skin, ears, or chin) and obsessive–compulsive disor-
der. It contains 12 self‐report items scored on a 5‐point (0–4) 
Likert‐type scale. A composite score ranging from 0 to 48 is 
created by adding together the scores on the 12 items. To our 
knowledge, reliability measures have not been published for 
the original MDSQ. In addition, no psychometric study has 
been conducted to analyze the properties of the MDSQ.
1.1.5 | MDS
The MDS was derived with the assistance of expert raters, 
and it consists of the 16 male eating behavior and body image 
evaluation items (MEBBIE; Kaminski & Caster, 1994; 
Kaminski et al., 2002) that were rated as the most likely to 
discriminate men suffering from MD from other men. The 
MEBBIE is a 57‐item self‐report instrument assessing men's 
attitudes and behaviors regarding eating, exercise, and body 
image. The internal consistency of the MDS was estimated 
using Cronbach's alpha, which was 0.80 (McFarland & 
Kaminski, 2009).
1.2 | Reliability generalization meta‐analysis
Reliability is one of the most important psychometric prop-
erties in developing instruments and conducting clinical 
studies. Reliability provides information about the degree of 
measurement precision associated with a test (Slaney, 2017). 
The amount of measurement error determines the validity 
of scores, and thus, the extent to which a measurement in-
strument is correctly representing a psychological construct 
(Flake, Pek, & Hehman, 2017).
However, reliability, like validity, is not an inherent prop-
erty of the test, but rather of the scores on a given application 
of the test. Because reliability changes as a function of the 
composition and variability of the sample to which the test 
is administered, researchers should routinely examine these 
psychometric properties (internal validity, score precision, 
and external validity) in the sample data (Slaney, 2017).
There are a number of different approaches to estimating 
the reliability of test scores (cf., e.g., Raykov & Marcoulides, 
1971): (a) temporal stability (e.g., test–retest reliability), 
(b) internal consistency (e.g., alpha coefficient), (c) parallel 
forms, and (d) inter‐rater or intra‐rater agreement. The meth-
ods based on internal consistency and test–retest are the most 
widely used (Flake et al., 2017). The internal consistency 
assesses the degree to which parts (i.e., items) or compo-
nents (i.e., subsets, halves) of a test are correlated. The most 
common measure of internal consistency used is Cronbach's 
alpha (e.g., Flake et al., 2017), which is the mean of all 
possible split‐half reliabilities (Cronbach, 1951). However, 
Cronbach's alpha has been criticized because it does not ad-
equately reflect the structure of the test (Revelle & Zinbarg, 
2009; Sijtsma, 2009). The test–retest method captures the 
temporal stability of the scores, that is, the extent to which a 
person's performance is repeatable (Raykov & Marcoulides, 
1971). The test–retest reliability is defined as the correlation 
between the scores obtained on the same test to the same 
group of examinees on two occasions separated by a specific 
time interval (e.g., days, weeks, months). If the test scores 
are reliable, the scores each examinee receives on the first 
administration should be similar to the scores on the second 
one. Thus, a large positive correlation would be expected 
between the two administrations of the test. However, fac-
tors such as memory, practice effects, or learning may affect 
the value of the test–retest coefficient when the time interval 
between the two assessments is short. Although, there is no 
consensus about the optimal time required between test and 
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retest to assess dependability and stability. Chmielewski and 
Watson (2009) pointed out that a time lag of two weeks is an 
index of dependability.
Prior studies show that a high proportion of researchers 
do not report reliability estimates from the sample data; in-
stead, they induce it from previous applications of the test 
(e.g., from validation studies of the test). For instance, a re-
cent systematic review conducted on 123 psychological tests 
and more than 41,000 empirical studies showed that 78.6% of 
them did not report reliability estimates with the data at hand, 
but they induced reliability from previous studies (Sánchez‐
Meca, Rubio‐Aparicio, López‐Pina, Núñez‐Núñez, & Marín‐
Martínez, 2015). The erroneous practice of not reporting 
reliability estimates from their own data has been called 
“reliability induction” (Vacha‐Haase, Kogan, & Thompson, 
2000), and it is based on incorrectly considering reliability 
to be a stable property of a measurement instrument across 
administrations, meaning that the composition and character-
istics of the samples of participants and the application con-
text, as well as the number of items on the test, have no effect 
on the reliability of the test scores. Two types of reliability 
induction can be considered: (a) induction by omission con-
sists of not offering data or information about the reliability 
of test scores, and (b) induction by report implies reporting 
the reliability of test scores based on previous studies (which 
assumes that evidence extends to the current study). In turn, 
two types of induction by report can be distinguished: reli-
ability induction by vague report and reliability induction by 
precise report. The former consists of referring to the reli-
ability of the test scores, but not reporting specific estimates 
(e.g., “previous studies have demonstrated that the test has 
good reliability”), whereas the latter occurs when specific es-
timates are reported (e.g., “in a previous validation of the test, 
a coefficient alpha of 0.8 was found”).
Fortunately, many researchers do not induce the re-
liability of test scores, but instead they report reliability 
estimates with the data at hand. Therefore, it is possible 
to investigate how the composition and variability of the 
samples used in different administrations of a given test 
and methodological factors can affect the reliability of the 
test scores. A reliability generalization (RG) meta‐analy-
sis is a suitable method to statistically integrate the reli-
ability estimates obtained in different applications of a test 
(Vacha‐Haase, 1998). RG meta‐analysis allows researchers 
to characterize the average reliability of scores obtained 
by a test across multiple studies and situations and esti-
mate the degree of variability in reliability coefficients 
across different types of measures, samples, and contexts. 
Furthermore, when reliability coefficients are heteroge-
neous, RG meta‐analysis allows us to explore which char-
acteristics of the studies may be statistically related to the 
reliability estimates (Rodriguez & Maeda, 2006; Sánchez‐
Meca, López‐López, & López‐Pina, 2013; Vacha‐Haase, 
Henson, & Caruso, 2002). In this way, it is possible to as-
certain which measures tend to produce the most reliable 
scores, for what types of people, and in what contexts.
1.3 | Purpose
The accurate and appropriate assessment of MD symptoma-
tology is of considerable importance given that it allows 
us to correctly identify people at risk of developing future 
psychological disorders and/or evaluate the efficacy of psy-
chological treatments. The accurate and appropriate use of 
a measurement instrument requires an understanding of the 
psychometric properties of the scores it produces. An RG 
meta‐analysis contributes to improving our knowledge about 
the reliability of test scores, as well as the factors involved 
in the variability in the scores’ reliability when a test is used 
in different contexts and populations. The results of an RG 
meta‐analysis can be very useful to help researchers, test ad-
ministrators, and practitioners (e.g., clinical professionals) to 
select the best measurement tools available for assessing MD 
in individual cases and when conducting research (Vacha‐
Haase et al., 2002).
Within this context, this study used an RG meta‐analysis 
to examine self‐report measures of MD symptomatology with 
the following aims: (a) to estimate the reliability induction 
rates of each of the tools; (b) to estimate the average reliabil-
ity of test scores (for the total scale and subscales), in terms 
of internal consistency and test–retest, found in the empirical 
studies that applied each of the tools and reported reliability 
estimates with the data at hand; (c) to examine the variability 
among the reliability estimates; (d) to search for substantive 
and methodological characteristics of the studies that can be 
statistically associated with the reliability coefficients; and 
(e) to investigate the generalizability of the results of our RG 
meta‐analyses by comparing the sample characteristics of the 
studies that induced reliability with those that reported re-
liability estimates with the data at hand. Consequently, this 
RG study describes the average reliabilities of scores pro-
duced by these measures and the degree to which the reli-
ability of these scores varies across studies. Furthermore, it 
describes the sample and study characteristics that explain 
the variance in score reliabilities. These results enable us to 
offer guidelines to applied researchers and practitioners about 
which scales are more reliable for assessing MD and in what 
circumstances.
2 |  METHODS
We conducted an RG meta‐analysis, based on the Guidelines 
for conducting and reporting reliability generalization meta‐
analyses (REGEMA; Sánchez‐Meca et al., 2017), on each of 
the scales developed to assess MD.
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2.1 | Selection criteria of the studies
The studies had to meet the following inclusion criteria: (a) 
the study had to be an original, quantitative investigation; 
(b) it had to assess MD using measurement instruments that 
specifically assessed the symptoms of MD and its diagnostic 
criteria (e.g., MASS, MDDI, and MDI.); (c) it had to report 
any reliability estimates based on the study‐specific sample; 
(d) samples of participants from any target population were 
accepted (community, gymnasiums, university, clinical or 
subclinical populations); (e) the paper could be published or 
unpublished; and (f) the paper had to be written in English, 
Spanish, Italian, or Portuguese. For the studies that induced 
reliability, the selection criteria were the same, with the ex-
ception of (c). No limits on the date of the study or the age 
of the participants were established. The following exclusion 
criterion was applied: N = 1 or case series studies. Finally, 
studies that applied any measurement instrument to assess 
MD and did not report reliability were also analyzed to com-
pare the sample characteristics of the studies that reported 
and induced reliability.
2.2 | Search strategy
Electronic searches were carried out in June 2018 in the 
Medline (via PubMed), PsycInfo, Science Direct, and Web 
of Science databases, using the following terms in all fields: 
muscle dysmorph*, muscle dysmorphia, reverse anorexia, 
bigorexia, vigorexia, and Adonis complex. Furthermore, 
manual searches of lists of references from the retrieved stud-
ies were conducted to identify additional studies that met the 
selection criteria. This search yielded five additional eligible 
studies. In addition, lists of references from previous reviews 
and meta‐analyses (e.g., Mitchell et al., 2017; Sandgren & 
Lavallee, 2018; Santos Filho, Tirico, Stefano, Touyz, & 
Claudino, 2015; Suffolk, Dovey, Goodwin, & Meyer, 2013; 
Tod & Edwards, 2015a) were screened to find studies that 
met the inclusion criteria for the present meta‐analysis. 
Finally, in order to locate unpublished papers, e‐mails were 
sent to 12 of the most prolific authors in the field. Six re-
sponses were obtained, but none of them led to the discovery 
of an unpublished study.
The process of determining the eligibility of the studies 
for this meta‐analysis was independently carried out by two 
researchers (both psychologists who had a PhD in psychol-
ogy and specialized in meta‐analysis). Disagreements be-
tween the raters were resolved by consensus.
2.3 | Data extraction
A protocol for extracting the characteristics of the stud-
ies was established and applied to each study. The char-
acteristics coded were as follows: (a) means and standard 
deviations of the total scores on the measurement instru-
ments and on each of the subscales; (b) means and standard 
deviations of the participants’ age (in years); (c) gender 
distribution of the sample (% male); (d) sample ethnicity 
(% White); (e) target population I (community, gymna-
siums, undergraduate students, subclinical, clinical, and 
Anabolic androgenic steroid [AAS]); (f) target population 
II (adults, adolescents, or mixed population); (g) percent-
age of clinical participants in the sample; (h) type of clini-
cal disorder (MD vs. other; for clinical samples only); (i) 
geographical location of the study (country and continent); 
(j) test version (English original vs. other); (k) study focus 
(psychometric vs. applied); (l) focus of the psychometric 
study (tools for assessing MD vs. another scale); (m) re-
search design (experimental, quasi‐experimental, or non-
experimental); (n) sample size; (o) time interval (in weeks) 
for test–retest reliability; (p) year of the study; (q) study 
language; (r) training of the main researcher (psychol-
ogy, psychiatry, other); (s) funding (yes/no); and (t) type 
of funding (public vs. private). Along with these modera-
tor variables, reliability coefficients were extracted for the 
total scale and for the reported subscales.
The coding process was carried out in a standardized and 
systematic manner, and the data were doubly coded by two 
independent coders, both psychologists who had a PhD in 
psychology and specialized in meta‐analysis. Inter‐rater re-
liability was satisfactory, with a mean intraclass correlation 
of 0.96 (SD  =  0.046), ranging from 0.89 to 1 for continu-
ous variables, and with a mean kappa coefficient of 0.90 
(SD = 0.087), ranging from 0.80 to 1 for qualitative variables. 
Additionally, when there was disagreement on the coding, a 
reconciliation process was undertaken.
2.4 | Reliability estimates
Given that all the studies reported the alpha coefficient 
to assess the internal consistency reliability of the meas-
ures and/or the Pearson correlation coefficient to assess 
test–retest reliability (temporal stability), these two types 
of reliability coefficients were taken into account in this 
meta‐analysis. Thus, they were extracted for the total score 
and for each subscale of the measurement instruments. In 
order to normalize their distributions and stabilize their 
variances, the reliability coefficients were transformed. 
Alpha coefficients (αi) were transformed by applying the 
formula proposed by Bonett (2002), and Pearson correla-
tion coefficients, r, were translated to Fisher's Z (Sánchez‐
Meca et al., 2013). Then, to facilitate the interpretation of 
the results from each meta‐analysis, the average reliabil-
ity coefficients and their confidence limits, obtained with 
Bonett's or Fisher's Z transformations, were back‐trans-
formed into the coefficient alpha and Pearson correlation 
metrics, respectively.
   | 7 of 24RUBIO‐APARICIO et Al.
2.5 | Statistical analysis
Separate meta‐analyses were conducted for alpha coefficients 
and test–retest reliability coefficients. In addition, separate 
meta‐analyses were conducted for the reliability coefficients 
obtained from the total scale and for each subscale of each 
measurement instrument. In all cases, random‐effects mod-
els were assumed in the statistical calculations (Borenstein, 
Hedges, Higgins, & Rothstein, 2009; López‐López, Botella, 
Sánchez‐Meca, & Marín‐Martínez, 2013; Sánchez‐Meca et 
al., 2013). In each meta‐analysis, an average reliability coef-
ficient and a 95% confidence interval were calculated with 
the improved method proposed by Hartung and Knapp (2001; 
see also Sánchez‐Meca & Marín‐Martínez, 2008).
To assess the heterogeneity among reliability coeffi-
cients in each meta‐analysis, a forest plot was constructed. 
In addition, both Cochran's Q statistic and the I2 index were 
calculated. A Q statistic with p < .05 was indicative of hetero-
geneity among the effect sizes (Higgins, Thompson, Deeks, 
& Altman, 2003). The degree of this heterogeneity was esti-
mated using the I2 index. I2 values of around 25%, 50%, and 
75% denoted low, moderate, and large heterogeneity, respec-
tively (Huedo‐Medina, Sánchez‐Meca, Marín‐Martínez, & 
Botella, 2006).
For meta‐analyses with at least 15 coefficients where the 
reliability coefficients exhibited heterogeneity, moderator 
analyses were performed in order to identify the study char-
acteristics statistically associated with reliability. Weighted 
ANOVAs and meta‐regressions assuming a mixed‐effects 
model were applied for categorical and continuous mod-
erators, respectively, with the improved method proposed 
by Knapp and Hartung (2003; see also López‐López et al., 
2013; Viechtbauer, López‐López, Sánchez‐Meca, & Marín‐
Martínez, 2015).
All statistical analyses were performed by metafor in R 
(Viechtbauer, 2010).
3 |  RESULTS
3.1 | Selection process and reliability 
induction
Figure 1 shows a flowchart of the study screening and selec-
tion process. The search strategy produced a total of 3,577 
manuscripts. First, the titles and abstracts of the 3,577 manu-
scripts were scanned, and 630 relevant studies were prese-
lected based on the inclusion and exclusion criteria. Then, 
duplicates were eliminated (n = 462), leaving a total of 168 
studies to review. After reviewing the full text of the re-
maining articles, 104 articles met the selection criteria. Of 
104 articles that applied a test for assessing MD, only 69 of 
them reported some type of reliability coefficient. Thus, our 
RG study included 69 studies. The studies included in the 
meta‐analysis are marked with an asterisk in the references 
section.
Table 1 shows the frequency and percentage of reliability 
induction for each measure. Across all measures, 20.2% of 
the articles reviewed made no mention of reliability (induc-
tion by omission), and 13.5% of the articles induced reliabil-
ity from previous studies (induction by report) by reporting 
the reliability coefficient obtained by the authors of the orig-
inal measure during the development of the measure (10.6%) 
or by stating that the measure had been found to be reliable in 
the past (2.9%). In addition, 4.8% of the articles reported the 
reliability for their data, but in a form that made it impossible 
to use in this meta‐analysis. Finally, 61.5% of the final sample 
of articles reported exact reliability values for their own data, 
and they were used in this meta‐analysis.
3.2 | Mean reliability and heterogeneity
The present RG study focused on the 69 studies that reported 
reliability coefficients with the data at hand. Of these 69 stud-
ies, eight of them could not be included in this RG meta‐anal-
ysis for several reasons: five studies were excluded because 
they did not report exact reliability coefficient values; that is, 
they only provided a range of estimates, or they stated that 
all the alphas were higher than 0.8 (Cafri, van den Berg, & 
Thompson, 2006; Hale et al., 2013; Hildebrandt, Schlundt, 
Langenbucher, & Chung, 2006; Murray, Griffiths, Mond, 
Kean, & Blashill, 2016; Weingarden, Curley, Renshaw, & 
Wilhelm, 2017), two studies were excluded because they 
were the only ones that applied the MDS (McFarland & 
Kaminski, 2009) and Schuldnt's MDI (Wolke & Sapouna, 
2008, respectively), and another study was excluded because 
it applied the subscales of the MDI (40 items) in several sam-
ples, but it did not report the number of items on each sub-
scale (Lantz et al., 2002). In this case, e‐mails were sent to 
the authors of the study to obtain these data, but none of them 
replied to our request. Consequently, our RG meta‐analysis 
included 61 studies. In addition, as several studies reported 
reliability coefficients for two or more different samples, the 
database of our RG study included a total of 73 independent 
samples.1  The reliability coefficients reported in the 73 in-
dependent samples were alpha coefficients and/or test–retest 
correlations.
The total number of participants was N = 15,274 (min-
imum  =  10, maximum  =  1,039), with a mean of 209 par-
ticipants per sample (Median = 123; SD = 223). Of the 73 
independent samples, 65 (89%) appeared in articles written in 
English, and the eight remaining samples (11%) appeared in 
articles written in Spanish. Regarding the locations where the 
studies were conducted, four continents were represented in 
our RG study: North America, 38 samples (52.1%); Europe, 
21 samples (28.8%); Oceania, 10 samples (13.7%); and South 
America, 4 samples (5.5%).
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With regard to the measurement instrument used to as-
sess MD, 28 samples (38.4%) used the MASS, 22 samples 
(30.1%) used the MDDI, seven samples (9.6%) used the MDI 
(Rhea et al., 2004), six samples (8.2%) used the MDSQ, five 
samples (6.8%) used the ACQ, and four samples (5.5%) used 
the MDI developed by Short (2005). Finally, the MDI devel-
oped by Cubberley (2009) was represented by two samples 
(2.7%).
Separate meta‐analyses were conducted for each of these 
measurement instruments’ total score reliability and for each 
of the subscales. In addition, different meta‐analyses were 
performed for alpha and test–retest reliability coefficients. 
Although the statistical analyses were performed using 
Bonett’s (2002) transformation for coefficient alphas, Tables 
2‒4 and Figures 2 and 3 show the means and their respective 
confidence limits after being back‐transformed to the coeffi-
cient alpha or test–retest metric for the purpose of facilitating 
their interpretation.
Table 2 presents the main summary statistics for the 
alpha coefficients obtained for the MASS total scores and 
for each subscale, and Figure 2 displays a forest plot of 
the alpha coefficients for the MASS total scores in each 
study. The 26 estimates reported for the total scale ranged 
from 0.63 to 0.94, with a mean coefficient alpha of 0.87 
(95% CI [0.84, 0.89]). Furthermore, the subscales showed 
lower average reliability coefficients than the total scores, 
with MC yielding the largest estimates (M = 0.85, 95% CI 
[0.77, 0.91]), followed by BD (M  =  0.83, 95% CI [0.79, 
0.86) and MS (M = 0.82, 95% CI [0.75, 0.87]), with the 
SU (M = 0.80, 95% CI [0.71, 0.87]) and IR (M = 0.79, 95% 
CI [0.72, 0.84]) subscales yielding the poorest average 
reliabilities.
Table 2 also shows the main summary statistics for the 
test–retest reliability coefficients for the MASS, both for total 
scores and for each subscale. Only three studies reported this 
type of reliability. The three estimates reported for the total 
F I G U R E  1  REGEMA flow diagram 
of study selecting processArticles identified through electronic searches 
(n = 3,572)
Articles identified through 
other searches (n = 5) 
Total articles identified (N = 3,577) 
Articles selected on the basis of reading abstracts (n = 630)
Articles excluded  
(n = 64) 
Criteria 2: 64 
Articles that applied the scale/s 
(n = 104) 
Articles included in the meta-analysis  
(n = 61) 
Duplicate articles removed (n = 462) 
Full-text articles assessed for eligibility (n = 168) 
Articles that induced reliability 
(n = 35) 
Articles that reported some reliability 
coefficient  
(n = 69) 
Articles excluded from meta-analysis 
(n = 8) 
- Range of αs (n = 5) 
- Isolated use of the scales (n = 2) 
- Lack of information (n = 1)
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scale yielded a mean test–retest coefficient of 0.90 (95% CI 
[0.71, 0.97]). Again, the subscales showed lower average reli-
ability coefficients than the total scores, with IR yielding the 
largest estimates (M = 0.87, 95% CI [0.81, 0.91]), followed 
by SU (M = 0.87, 95% CI [0.83, 0.89) and MC (M = 0.86, 
95% CI [0.80, 0.91]), with the MS (M = 0.86, 95% CI [0.84, 
0.87]) and BD (M  =  0.82, 95% CI [0.69, 0.90]) subscales 
yielding the poorest average reliabilities.
Table 3 presents the main summary statistics for the alpha 
coefficients obtained for the MDDI total scores and for each 
subscale, and Figure 3 presents a forest plot of alpha coeffi-
cients for the MDDI total scores. The 17 estimates reported 
T A B L E  1  Frequency (and percentage) of reliability reporting practices for each measurement instrument of muscle dysmorphia
Measure
Induced reliability Reported reliability
By omission Vague report Precise report Unusable Usable (%)
MASS 8 (21.6%) 3 (8.1%) 1 (2.7%) 1 (2.7%) 24 (64.9)
MDDI — — 3 (14.3%) 2 (9.5%) 16 (76.2)
MDI (40 items) — — 1 (33.3%) — 2 (66.7)
MDI (34 items) — — — — 2 (100)
MDI (27 items) 3 (20%) 1 (6.7%) 3 (20%) 1 (6.7%) 7 (46.7)
MDI (25 items) — — 1 (20%) — 4 (80)
MDI (16 items) — — — — 1 (100)
MDS (57 items) — — — — 1 (100)
MDSQ (12 items) 6 (50%) — — 1 (8.3%) 5 (41.7)
ACQ (13 items) 4 (36.4%) — 2 (18.2%) — 5 (45.5)
Total 21 (20.2%) 3 (2.9%) 11 (10.6%) 5 (4.8%) 64 (61.5)
Note: The total row numbers reflect the number of unique articles that used each reporting type. Because three articles (Cafri et al., 2008; Cella et al., 2012; Ebbeck, 
Watkins, Concepcion, Cardinal, & Hammermeister, 2009) used multiple measures, the total does not reflect the sum of the measures.
Abbreviations: ACQ, Adonis Complex Questionnaire; MASS, Muscle Appearance Satisfaction Scale; MDDI, Muscle Dysmorphic Disorder Inventory; MDI, Muscle 
Dysmorphia Inventory; MDS, Muscle Dysmorphia Scale; MDSQ, Muscle Dysmorphia Symptom Questionnaire.




Total scale 26 0.87 0.84 0.89 353.63**** 93.45
BD 9 0.83 0.79 0.86 48.38**** 85.04
MC 8 0.85 0.77 0.91 192.02**** 95.89
SU 8 0.80 0.71 0.87 122.60**** 93.97
IR 8 0.79 0.72 0.84 36.72**** 82.76
MS 9 0.82 0.75 0.87 102.52**** 91.50
Test–retest reliability (2 weeks)
Total scale 3 0.90 0.71 0.97 35.06**** 92.55
BD 3 0.82 0.69 0.90 48.44**** 94.54
MC 3 0.86 0.80 0.91 18.59**** 86.57
SU 3 0.87 0.83 0.89 5.11 60.83
IR 3 0.87 0.81 0.91 13.48** 82.14
MS 3 0.86 0.84 0.87 0.30 0
Abbreviations: BD, Bodybuilding Dependence subscale; I2, heterogeneity index; IR, Injury subscale; k, 
number of studies; LL and UL, lower and upper limits of the 95% confidence interval for r+; MASS, Muscle 
Appearance Satisfaction Scale; MC, Muscle Checking subscale; MS, Muscle Satisfaction subscale; Q, 
Cochran's heterogeneity Q statistic; Q statistic has k—1 degrees of freedom; r+, average reliability coefficient; 
SU, Substance Use subscale.
**p < .01. 
****p < .0001. 
T A B L E  2  Average alpha coefficients 
and test–retest reliability, 95% confidence 
intervals, and heterogeneity statistics for the 
MASS total score and the five subscales
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for the total scale ranged from 0.68 to 0.92, with a mean 
coefficient alpha of 0.83 (95% CI [0.79, 0.86]). In addition, 
the subscales showed larger average reliability coefficients 
than the total scores, with DFS yielding the largest estimates 
(M = 0.86, 95% CI [0.79, 0.90]), followed by FI (M = 0.85, 
95% CI [0.80, 0.89), and the AI subscale yielding the poorest 
average reliabilities (M = 0.84, 95% CI [0.71, 0.91]).
Table 3 also shows the main summary statistics for the 
test–retest reliability coefficients for the MDDI, both for total 
scores and for each subscale. Once again, only three studies 
reported this type of reliability. The three estimates reported 
for the total scale yielded a mean test–retest coefficient of 
0.92 (95% CI [0.47, 0.99]). Furthermore, the DFS subscale 
showed a larger average reliability coefficient (M  =  0.93, 
95% CI [0.82, 0.97]) than that of the total scores. However, 
the rest of the subscales showed lower average reliability co-
efficients than the total scores, with the AI and FI subscales 
yielding the same estimates (M = 0.84, 95% CI [0.75, 0.90]; 
M = 0.84, 95% CI [0.75, 0.90], respectively).
Table 4 presents the main summary statistics for the alpha 
coefficients obtained for the total scores and for each sub-
scale of some of the other scales (three different versions of 
the MDI, the ACQ, and the MDSQ). For the MDI (34 items), 
the two estimates reported for the total scale were 0.90, with a 
mean coefficient alpha of 0.90 (95% CI [0.88, 0.92]); for the 
MDSQ, the six estimates reported for the total scale ranged 
from 0.75 to 0.94, with a mean coefficient alpha of 0.86 (95% 
CI [0.77, 0.91]); for the MDI (25 items), the four estimates 
reported for the total scale ranged from 0.79 to 0.87, with a 
mean coefficient alpha of 0.84 (95% CI [0.80, 0.87]); and for 
the ACQ, the five estimates reported for the total scale ranged 
from 0.70 to 0.88, with a mean coefficient alpha of 0.79 (95% 
CI [0.66, 0.87]).
For the MDI (27 items), only one alpha coefficient of 0.87 
was found for the total scores. For the subscales of the MDI 
(27 items), once again average reliability coefficients were 
lower than that of the total scores, with SU yielding the largest 
estimates (M = 0.84, 95% CI [0.68, 0.92]), followed by BS 
(M = 0.84, 95% CI [0.78, 0.89] and DB (M = 0.83, 95% CI 
[0.63, 0.92]), PP (M = 0.82, 95% CI [0.69, 0.90]), with the ED 
(M = 0.74, 95% CI [0.58, 0.84]), and PU (M = 0.68, 95% CI 
[0.23, 0.87]) subscales yielding the poorest average reliabili-
ties. Only one study reported test–retest reliability for the ACQ 
total scores, with an estimation of 0.71, 95% CI [0.43, 0.86].
Finally, a weighted ANOVA was performed to compare the 
average alpha coefficients for the total scores of the instruments 
analyzed. A marginally statistically significant difference was 
found among the average alpha coefficients, F(6,52) = 2.17, 
p = .061, and a 16% of explained variance. The largest average 
alpha coefficient was for studies that used the MDI (34 items), 
M  =  0.90, followed by the MDI (27 items), M  =  0.87, the 
MASS, M = 0.87, the MDSQ, M = 0.86, the MDDI, M = 0.83, 
the MDI (25 items), M = 0.80, and the ACQ, M = 0.79.
3.3 | Analysis of moderator variables
Because the alpha coefficients for the total scores on the 
MASS and the MDDI were the ones that presented more 
than 15 reliability estimates, the analysis of moderator vari-
ables was conducted only for these two scales. Specifically, 
weighted ANOVAs and simple meta‐regressions were per-
formed for continuous and categorical variables, respectively, 




Total scale 17 0.83 0.79 0.86 88.66**** 84.24
DFS 8 0.86 0.79 0.90 63.24**** 93.08
AI 8 0.84 0.71 0.91 352.19**** 97.64
FI 10 0.85 0.80 0.89 134.08**** 91.69
Test–retest reliability (1–3 weeks)
Total scale 3 0.92 0.47 0.99 29.37**** 93.82
DFS 3 0.93 0.82 0.97 6.14* 68.28
AI 3 0.84 0.75 0.90 0.34 0
FI 3 0.84 0.75 0.90 0.05 0
Abbreviations: AI, Appearance Intolerance subscale; DFS, Drive For Size subscale; FI, Functional Impairment 
subscale; I2, heterogeneity index; k, number of studies; LL and UL, lower and upper limits of the 95% confi-
dence interval for r+; MDDI, Muscle Dysmorphic Disorder Inventory; Q, Cochran's heterogeneity Q statistic; 
Q statistic has k—1 degrees of freedom; r+, average reliability coefficient.
*p < .05. 
****p < .0001. 
T A B L E  3  Average alpha coefficients 
and test–retest reliability, 95% confidence 
intervals, and heterogeneity statistics for the 
MDDI total score and the three subscales
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on alpha coefficients for the total scale, assuming mixed‐ef-
fects models.
Table 5 shows the results of the simple meta‐regressions 
applied on alpha coefficients for the total scores of the MASS 
and the MDDI. Note that the sign of the regression slope, 
bj, is obtained by taking the alpha coefficients transformed 
using Bonett’s (2002) formula as the dependent variable. 
Therefore, the direction of the true association between the 
alpha coefficients and each moderator is the inverse of what 
is represented by the sign of the slope in Table 5. For the 
MASS total scores, only the mean age of the participants 
showed a negative, statistically significant association with 
the alpha coefficient (p =  .048), accounting for 20% of the 
variance. With regard to the MDDI, none of moderators an-
alyzed showed a relationship with the alpha coefficient, al-
though for the variable ethnicity (percentage of Caucasians), 
a marginally statistically significant relationship was found, 
accounting for 41% of the variance.
Regarding the categorical moderators, Tables 6 and 7 
present the results of the weighted ANOVAs applied to alpha 
coefficients for the total scores on the MASS and the MDDI, 
respectively. Regarding the MASS, none of the moderator 
variables analyzed revealed a statistically significant rela-
tionship with the alpha coefficient for the total scores on the 
MASS.
With regard to the MDDI, two moderator variables ex-
hibited a statistically significant association with the reliabil-
ity estimates: the study focus and the training of the main 
researcher of the study. The study focus, classified as psy-
chometric versus applied, accounted for 24% of the variance 
(p = .050). Specifically, the average reliability was higher for 
psychometric studies (M = 0.89), compared to applied studies 
with a substantive purpose (M = 0.82). In addition, the train-
ing of the main researcher also revealed a statistically sig-
nificant relationship with the alpha coefficients (p =  .039), 





Total scale 2 0.90 0.88 0.92 0 0
MDI (27 items)
Total scale 1 0.87 0.81 0.91 — —
PP 6 0.82 0.69 0.90 124.95**** 97.03
DB 5 0.83 0.63 0.92 144.44**** 97.81
BS 5 0.84 0.78 0.89 32.71**** 89.57
PU 5 0.68 0.23 0.87 195.93**** 98.01
SU 5 0.84 0.68 0.92 93.54**** 97.38
ED 5 0.74 0.58 0.84 65.61**** 94.39
MDI (25 items)
Total scale 4 0.84 0.80 0.87 10.61* 68.7
MDSQ (12 items)
Total scale 6 0.86 0.77 0.91 32.45**** 92.77
ACQ (13 items)
Total scale 5 0.79 0.66 0.87 31.09**** 89.88
PEPA 1 0.88 0.83 0.91 — —
COPA 1 0.75 0.61 0.82 — —
CAPA 1 0.70 0.58 0.79 — —
Abbreviations: ACQ, Adonis Complex Questionnaire; BS, Body Size/Symmetry subscale; CAPA, Concerns 
About Physical Appearance subscale; CTPA, Control Over Physical Appearance subscale; DB, Dietary 
Behavior subscale; ED, Exercise Dependence subscale; I2, heterogeneity index; k, number of studies; LL and 
UL = lower and upper limits of the 95% confidence interval for r+; MDI, Muscle Dysmorphia Inventory; 
MDSQ, Muscle Dysmorphia Symptom Questionnaire; PEPA, Psychosocial Effect of the Physical Appearance 
subscale; PP, Physique Protection subscale; PU, Pharmacological Use subscale; Q, Cochran's heterogeneity 




T A B L E  4  Average alpha coefficients, 
95% confidence intervals, and heterogeneity 
statistics for other scales
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coefficients for studies conducted by psychiatrists and people 
with physical activity training (M = 0.88, 0.81, respectively), 
and the lowest average for studies conducted by psychologists 
(M = 0.80).
Finally, there were two moderator variables that showed 
no statistically significant relationships with the reliabil-
ity coefficients, but they accounted for a small but relevant 
proportion of variance. This was the case of study character-
istics such as (a) the type of research design (experimental, 
quasi‐experimental, nonexperimental), with better reliabil-
ity estimates obtained by studies that used an experimental 
design (M  =  0.89) than by those that used other research 
designs (M = 0.82; R2 = 0.11), and (b) the financial source 
(public funding, private funding, no funding), with a higher 
average reliability coefficient for studies that were financed 
(Mpublic = 0.86, Mprivate = 0.85) than for those that were not 
(M = 0.80; R2 = 0.12).
3.4 | A comparison of the characteristics of 
studies inducing and reporting reliability
Another aim in our RG meta‐analysis was to examine the ex-
tent results can be generalized to the population of studies that 
have applied the MASS and the MDDI tests, regardless of 
whether they reported or induced reliability. For this purpose, 
the characteristics of the samples used in studies that reported 
and induced test score reliability were compared. Specifically, 
studies reporting and inducing reliability were compared on the 
mean and standard deviation of the total scores, as well as the 
mean and standard deviation of the age, gender (% male), and 
ethnic distribution (% White) of the participants in the samples.
Table 8 shows the results of comparing the means of stud-
ies that induced and reported reliability. It can be noted that 
there were no differences in any sample characteristics be-
tween studies that induced or reported reliability.
F I G U R E  2  Forest plot displaying the alpha coefficients (and 95% confidence intervals) for the Muscle Appearance Satisfaction Scale total 
score
   | 13 of 24RUBIO‐APARICIO et Al.
4 |  DISCUSSION
Separate RG meta‐analyses were performed to estimate the 
reliability of each of the scales developed to assess MD and 
identify the characteristics of studies statistically associated 
with the variability in the reliability coefficients. We also 
estimated the reliability induction rate when using these 
measures, and we compared the characteristics of studies that 
reported or induced reliability. Our RG meta‐analysis was 
based on a total of 60 studies (72 independent samples) that 
reported any internal consistency and/or test–retest reliability 
estimates with the data at hand.
We found that 61.2% of the articles examined reported 
exact Cronbach's alpha values and/or test–retest coefficients 
for their own data and could be used in this meta‐analy-
sis. This percentage of articles providing usable reliability 
coefficients is quite high compared to other RG studies, 
which have lower average reporting rates (Sánchez‐Meca 
et al., 2015; Vacha‐Haase, Ness, Nilsson, & Reetz, 1999; 
Whittington, 1998). However, approximately 34% of the 
studies examined induced reliability from previous studies, 
which is disappointing given that score reliability should 
be reported every time a measure is used. In this regard, 
it is important for researchers to evaluate psychometric 
properties of the tests used (i.e., reliability and validity) 
with their sample because characteristics of the sample af-
fect test score reliability and validity (e.g., Fried & Flake, 
2018). These analyses will allow us to determine the mea-
surement accuracy and whether the test is measuring the 
same psychological construct as in the previous studies 
where it was validated (Hussey & Hughes, 2018). Without 
this information, it is not possible to know whether re-
searchers are drawing erroneous conclusions and making 
incorrect recommendations, given that the findings depend 
on the validity of the measurement tools used to assess the 
psychological construct (Flake et al., 2017). In other words, 
in order to draw accurate conclusions based on the data 
collected from administering a test, evidence of the validity 
and reliability of the test scores is required.
Recommendations for reporting reliability estimates of 
test scores with the data at hand have been proposed by the 
American Psychological Association Task Force on Statistical 
Inference (Wilkinson & the APA Task Force for Statistical 
Inference, 1999); editorial policies of scientific journals such 
as Educational and Psychological Measurement (Thompson, 
1994) and the Journal of Experimental Education (Heldref 
Foundation, 1997); and scientific associations such as the 
National Research Council on Measurement in Education and 
the American Educational Research Association. In addition, 
recently, the American Psychological Association's reporting 
standards for quantitative studies specifically recommended: 
“Estimate and report values of reliability coefficients for the 
scores analyzed (i.e., the researcher's sample), if possible” 
(Appelbaum et al., 2018, Table 1, p. 7).
In most of the articles that estimated the reliability of 
test scores to assess MD, only one type of reliability was 
reported, mostly Cronbach's alpha for internal consistency, 
followed by test–retest correlations. These findings agree 
with prior studies that analyzed the characteristics of reliabil-
ity coefficients reported in papers and found similar results 
F I G U R E  3  Forest plot displaying 
the alpha coefficients (and 95% confidence 
intervals) for the Muscle Dysmorphic 
Disorder Inventory total score
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regarding the popularity of Cronbach's alpha and test–re-
test correlation estimates of score reliability (e.g., Barry, 
Chaney, Piazza‐Gardner, & Chavarria, 2014; Flake et al., 
2017). However, Cronbach's alpha is not the most adequate 
reliability coefficient (Revelle & Zinbarg, 2009), and it is 
strongly affected by the length of the test (Streiner, 2003). 
Furthermore, Cronbach's alpha does not reflect the structure 
of the test (Revelle & Zinbarg, 2009; Sijtsma, 2009). There 
are other estimates of internal consistency that are reported 
less frequently but are better alternatives to Cronbach's 
alpha to assess reliability, such as Omega total (ωt) and 
Omega hierarchical (ωh), introduced by McDonald (1978, 
1999, respectively). Consequently, researchers should adopt 
a more comprehensive assessment following best practices 
(e.g., Fried & Flake, 2018; Hussey & Hughes, 2018; Slaney, 
2017), which recommend to “stop using Cronbach's alpha as 
a sole source of validity evidence” (Fried & Flake, 2018) and 
checking the underlying factor structure of the test and its 
invariance across samples, as in the current study.
Regarding average reliability estimates, psychometric the-
ory points out that the internal consistency reliability of test 
scores must be over 0.80 for research purposes and over 0.90 
for clinical practice. However, alpha coefficients greater than 
0.70 can be considered acceptable for exploratory research 
(Charter, 2003; Nunnally & Bernstein, 1994). In addition, to 
assess the clinical relevance of the alpha coefficients of test 
Predictor 





14 −0.05 0.27 .611 55.32**** 0.0
SD of total 
score
14 −0.05 0.01 .915 58.55**** 0.0
Mean age 
(years)
25 0.04 4.36 .048 219.37**** 0.20
SD of age 
(years)
23 0.03 1.28 .271 278.21**** 0.04
Gender (% 
male)
25 −0.0001 0.00 .964 350.11**** 0.0
Ethnicity (% 
Caucasian)
12 −0.0009 0.02 .889 260.53**** 0.0
Year of the 
study




14 0.01 0.01 .952 56.36**** 0.0
SD of total 
score
14 0.02 0.18 .681 56.15**** 0.0
Mean age 
(years)
17 0.002 0.02 .892 87.50**** 0.0
SD of age 
(years)
17 0.03 1.55 .233 78.43**** 0.06
Gender (% 
male)
17 0.002 0.36 .555 88.66**** 0.0
Ethnicity (% 
Caucasian)
8 −0.01 4.86 .069 34.33**** 0.41
Year of the 
study
17 0.006 0.05 .821 88.53**** 0.0
Abbreviations: bj, regression coefficient of each predictor; F, Knapp–Hartung's statistic for testing the 
significance of the predictor (the degrees of freedom for this statistic are 1 for the numerator and k—2 for the 
denominator); k, number of studies; MASS, muscle appearance satisfaction Scale; MDDI, Muscle Dysmorphic 
Disorder Inventory; p, probability level for the F statistic; QE, statistic for testing the model misspecification; 
R2, proportion of variance accounted for by the predictor.
****p < .0001. 
T A B L E  5  Results of the simple meta‐
regressions applied on alpha coefficients for 
the MASS and MDDI total scores, taking 
continuous moderator variables as predictors




Test version         F(4,21) = 0.33, p = .858
R2 = 0.0
QW(21) = 294.37, p < .0001
Original (English) 14 0.86 0.83 0.89
Spanish 8 0.88 0.83 0.91
Hungarian 2 0.88 0.78 0.93
Peruvian 1 0.82 0.52 0.93
Mexican 1 0.82 0.60 0.92
Test version (dich.)         F(1,24) = 0.03, p = .860
R2 = 0.0
QW(24) = 346.08, p < .0001
Original (English) 14 0.86 0.83 0.89
Other 12 0.87 0.83 0.90
Study focus         F(1,24) = 0.63, p = .437
R2 = 0.0
QW(24) = 352.62, p < .0001
Psychometric 7 0.88 0.84 0.91
Applied 19 0.86 0.83 0.88
Psychometric focus         F(1,5) = 0.08, p = .785
R2 = 0.0
QW(5) = 155.76, p < .0001
MASS 6 0.88 0.80 0.93
Other 1 0.86 0.49 96
Target population I         F(1,24) = 0.49, p = .491
R2 = 0.0
QW(24) = 353.53, p < .0001
Adult 24 0.86 0.84 0.88
Adult + adolescent 2 0.89 0.81 0.93
Target population II         F(4,21) = 0.27, p = .892
R2 = 0.0
QW(21) = 291.76, p < .0001
Community 2 0.89 0.81 0.94
Undergraduate 7 0.86 0.81 0.90
Gym 13 0.87 0.84 0.90
Comm. + underg. 1 0.86 0.68 0.94
Underg. + gym 3 0.84 0.74 0.91
Continent         F(3, 22) = 0.49, p = .691
R2 = 0.0
QW(22) = 272.91, p < .0001
Europe 11 0.88 0.84 0.90
N. America 9 0.86 0.82 0.89
S. America 3 0.83 0.73 0.90
Oceania 3 0.88 0.81 0.92
Study language         F(1,24) = 2.97, p = .098
R2 = 0.08
QW(24) = 310.67, p < .0001
English 21 0.87 0.85 0.89
Spanish 5 0.83 0.75 0.88
Main researcher         F(2,23) = 0.36, p = .701
R2 = 0.0
QW(23) = 302.19, p < .0001
Psychologist 16 0.86 0.83 0.89
Psychiatrist 2 0.86 0.75 0.92
Physical activity 
training
8 0.88 0.84 0.91
Financial source         F(1, 24) = 0.17, p = .682
R2 = 0.0
QW(24) = 325.99, p < .0001
Public funding 3 0.85 0.77 0.91
No funding/no 
reported
23 0.87 0.84 0.89
Abbreviations: MASS, Muscle Appearance Satisfaction Scale; k, number of studies; α+, mean coefficient 
alpha; LL and LU, lower and upper 95% confidence limits for α+; F, Knapp–Hartung's statistic for testing the 
significance of the moderator variable; QW, statistic for testing the model misspecification; R
2, proportion of 
variance accounted for by the moderator.
T A B L E  6  Results of the weighted 
ANOVAs applied on alpha coefficients for 
the MASS total score, taking qualitative 
moderator variables as independent 
variables
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scores, Cicchetti (1994) suggested the following guidelines: 
unacceptable for coefficients lower than 0.7, fair for the range 
from 0.7 to 0.8, good for 0.8 to 0.9, and excellent for val-
ues over 0.9. However, it must be taken into account that, as 
Streiner (2003) points out, higher alpha values (over 0.90) 
“may reflect unnecessary duplication of content across items 
and point more to redundancy than to homogeneity” (p. 102). 
Therefore, higher alpha values do not guarantee the internal 
consistency of the test. Following these guidelines, the aver-
age internal consistency reliability of the total scores on all 
the instruments analyzed, except the ACQ, can be considered 
good, both for research and clinical practice. The average 
alpha coefficient for the ACQ was 0.79, which is in the range 




Test version         F(1,15) = 0.04, p = .849
R2 = 0.0
QW(15) = 86.97, p < .0001
Original (English) 14 0.83 0.79 0.86
Italian 3 0.83 0.75 0.89
Study focus         F(1,15) = 4.53, p = .050
R2 = 0.24
QW(15) = 69.39, p < .0001
Psychometric 2 0.89 0.82 0.93
Applied 15 0.82 0.78 0.85
Type of research         F(1,15) = 2.70, p = .121
R2 = 0.11
QW(15) = 81.59, p < .0001
Experimental 2 0.89 0.80 0.94
Quasi‐experimental — — — —
No experimental 15 0.82 0.78 0.85
Target population I         F(1,15) = 0.19, p = .671
R2 = 0.0
QW(15) = 88.09, p < .0001
Adult 16 0.83 0.79 0.86
Adult + adolescent 1 0.80 0.57 0.91
Target population II         F(6,10) = 0.86, p = .553
R2 = 0.0
QW(10) = 65.66, p < .0001
Undergraduate 6 0.81 0.73 0.86
Gym 4 0.85 0.78 0.90
Subclinical 1 0.76 0.47 0.89
Clinical 2 0.83 0.64 0.92
Comm. + underg. 2 0.89 0.78 0.95
Comm. + gym 1 0.85 0.68 0.93
Underg. + clinical 1 0.78 0.52 0.90
Continent         F(2,14) = 0.19, p = .825
R2 = 0.0
QW(14) = 85.71, p < .0001
Europe 3 0.83 0.74 0.89
N. America 10 0.83 0.78 0.87
Oceania 4 0.81 0.70 0.88
Main researcher         F(2,14) = 4.09, p = .039
R2 = 0.35
QW(14) = 52.66, p < .0001
Psychologist 11 0.80 0.76 0.84
Psychiatrist 5 0.88 0.83 0.91
Physical activity 
training
1 0.81 0.63 0.90
Financial source         F(2,14) = 1.99, p = .173
R2 = 0.12
QW(14) = 67.01, p < .0001
Public funding 7 0.86 0.81 0.89
Private funding 1 0.85 0.71 0.92
No funding/no 
reported
9 0.80 0.74 0.84
Abbreviations: MDDI, Muscle Dysmorphic Disorder Inventory; K, number of studies; α+, mean coefficient 
alpha; LL and LU, lower and upper 95% confidence limits for α+; F, Knapp–Hartung's statistic for testing the 
significance of the moderator variable; QW, statistic for testing the model misspecification; R
2, proportion of 
variance accounted for by the moderator.
T A B L E  7  Results of the weighted 
ANOVAs applied on alpha coefficients for 
the MDDI total score, taking qualitative 
moderator variables as independent 
variables
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should be interpreted with caution when this instrument is 
used in a clinical context.
When the average alpha coefficients for each scale's total 
scores were compared, only marginally statistically signif-
icant differences were found. The small number of studies 
representing several of the scales analyzed probably reduced 
the power of this comparison. The largest average alpha coef-
ficients were found for the MDI (34 items) and the MDI (27 
items), 0.90 and 0.87, respectively. However, these results 
were based on only two and one studies, respectively. This 
circumstance limits the generalizability of these results. The 
next scale with the largest average alpha coefficient was the 
MASS (M = 0.87), and this scale was the best represented in 
our meta‐analysis, with 26 studies. Therefore, we can pro-
pose the MASS as the scale that, in general, seems to present 
better reliability (internal consistency) than the other scales 
compared here to assess MD.
In the case of the subscales, overall they all can be con-
sidered good, both for research and clinical practice, because 
their average alpha coefficients were above 0.80, except the 
IR subscale of the MASS, and two subscales of the MDI (27 
items): ED and PU. The coefficients for the IR subscale of 
the MASS (0.79) and for the ED subscale of the MDI (27 
items) (0.74) are in the range of acceptable reliability for their 
use for research purposes, but not for making decisions in 
clinical practice. In contrast, the average coefficients for PU 
(0.68) showed that the subscale does not possess the min-
imum levels of reliability required for clinical and general 
research purposes. Thus, its use should be limited to explor-
atory research.
With regard to test–retest reliability coefficients for total 
scores, Pearson correlations exhibited means of 0.90 for the 
MASS, 0.92 for the MDDI, and 0.71 for the ACQ. There is no 
consensus in the literature about guidelines for interpreting 
the adequacy of test–retest coefficients (Charter, 2003). In 
addition, as we mentioned earlier, test–retest reliability es-
timates are affected by the length of the retest interval. In 
this way, test–retest reliability measures dependability in 
the short term or stability over a longer term (e.g., Cattell, 
Eber, & Tatsuoka, 1970). Given that the studies included in 
Variable
Inducing Reporting
t p dMean(SD) Mean(SD)
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Abbreviations: d, standardized mean difference; MASS, muscle appearance satisfaction scale; MDDI, muscle 
dysmorphic disorder inventory; nI and nR, sample sizes of inducing and reporting studies, respectively; p, prob-
ability level associated to the t test; t, t test for comparing two means.
T A B L E  8  Results of comparing the 
means of studies that induce and report 
reliability
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this RG meta‐analysis used 1–3 week intervals between test 
and retest, according to the criteria of Cattell et al. (1970), 
the values of test–retest correlations might be considered an 
index of dependability and not temporal stability. In this case, 
the differences between scores on the test and retest might 
reflect measurement error, which might suggest assessment 
problems (Watson, 2004). In this context, a high test–retest 
reliability correlation would be desirable because it would 
indicate a high degree of measurement precision. According 
to the criteria of Gliner, Morgan, and Leech (2009), test–
retest reliability can be considered high if it is above 0.80. 
Following this guideline, the MASS and the MDDI total 
scores showed adequate reliability, and the ACQ total score 
showed fair reliability (between 0.7 and 0.8). In addition, 
test–retest reliability coefficients for subscales of the MASS 
and the MDDI, according to the criteria of Gliner et al. 
(2009), showed acceptable reliability (ranging between 0.82 
and 0.87, and between 0.84 and 0.93, respectively). In this 
context, the ACQ total score would show less measurement 
precision. Nevertheless, it must be noted that these findings 
on test–retest coefficients should be interpreted with caution 
due to the scarcity of studies reporting these coefficients and 
the short periods between test and retest. In addition, it must 
be taken into account that factors such as memory might have 
affected the value of the test–retest coefficient (e.g., overes-
timating the average reliability). Moreover, it is worth noting 
that other authors have pointed out other interval periods to 
indicate whether test–retest reliability measures dependabil-
ity (in the short term: 45 min) or stability (over a longer term: 
1–4 weeks; Revelle & Condon, 2018). According to the cri-
teria of Revelle and Condon (2018), studies included in this 
meta‐analysis would be assessing test–retest reliability as 
temporal stability. In this case, a large test–retest correlation 
over a long period of time would indicate temporal stability. 
In this context, the ACQ total score would show poor stability 
across time.
On the other hand, the alpha coefficients presented great 
heterogeneity across studies that sampling error alone might 
not explain. This means that the reliability of the test scores 
analyzed cannot be generalized across their applications be-
cause reliability varies depending on the context where the 
test was applied, the characteristics of the studies, and the 
composition, target population, and variability of the sam-
ples. Therefore, researchers should examine the reliability for 
their sample every time a measure is used, given that char-
acteristics of the studies and the composition of the samples 
affect test score reliability.
On the other hand, analyses of moderator variables 
were only conducted on total scores for the MASS and the 
MDDI, due to the small number of the studies that used 
other instruments to assess MD. These moderator analy-
ses allowed us to know which characteristics of the stud-
ies exhibited a statistical relationship with the reliability 
coefficients for the MASS and the MDDI total scores. 
The target population (e.g., community, gymnasiums, un-
dergraduate students, subclinical, clinical, and AAS) did 
not show a statistical relationship with the reliability co-
efficients for the MASS and the MDDI total scores, which 
means that the target population does not affect the reliabil-
ity of these measures. Therefore, the MASS and the MDDI 
are equally reliable, regardless of the target population, 
and, consequently, they work equally well in any sample. 
For the MASS total scores, only the mean age of the partic-
ipants showed a negative statistically significant relation-
ship with reliability estimates, which means that samples 
with younger participants exhibited better average reliabil-
ity than samples with older participants. This result sug-
gests that the MASS may be particularly well suited, not 
only as a general measure of MD but also in making cross‐
group comparisons between participants from a variety of 
backgrounds, except when the participants have different 
ages. On the other hand, for the MDDI total scores, the 
study focus and the training of the main researcher of the 
study showed a relationship with the reliability estimates. 
Specifically, the average reliability was higher for psycho-
metric studies than for applied ones. In addition, larger av-
erage alpha coefficients were found for studies conducted 
by psychiatrists and people with physical activity training 
than for those conducted by psychologists. These findings 
show different sources of variability that may explain, in 
part, the heterogeneity noted among reliability coefficients 
across studies, as well as the dependence that measure-
ment reliability exhibits from specific applications of the 
instrument.
The last objective of our research was to determine to 
what extent results of our RG meta‐analysis may be gener-
alized to the total population of studies that have applied the 
MASS and the MDDI test. As Sterne et al. (2011) point out, 
the results of an RG meta‐analysis can be generalized to the 
total population of studies if the studies that reported reliabil-
ity used samples similar in composition and variability to the 
studies that induced it. Therefore, reporting bias, in terms of 
reliability, can be ruled out as a threat to the validity of meta‐
analytic results. No differences were found between the two 
groups of studies. Therefore, our results can be reasonably 
generalized to all the studies that applied the MASS and the 
MDDI test.
4.1 | Limitations and future research
The main limitation of our study was the small number of 
articles that reported test–retest correlations, which limited 
the generalizability of our results on the temporal stability 
of the test scores and did not allow us to examine modera-
tor variables related to test–retest estimates. Future studies 
should include test–retest reliability, that is, a measure of the 
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consistency of the measurement across time. Without this in-
formation, it is not known whether changes in scores reflect 
real changes in the measurement variable or only variations 
in scores due to test–retest reliability.
Another limitation was the small number of alpha coeffi-
cient estimates included in some of the meta‐analyses (e.g., 
k = 2 or k = 3), which limited the possibility of conducting 
moderator analyses.
Finally, it must be taken into account that this study 
examined the reliability (i.e., Cronbach's alpha coefficient 
and test–retest reliability) of the self‐report measures of 
MD across different samples or settings, but it did not ana-
lyze their structural validity. Therefore, this work does not 
provide information about whether the measures included 
in this RG meta‐analysis are actually measuring MD across 
populations or settings. Future studies should analyze the 
structural validity of these measures across different pop-
ulations and settings. Without this information, it is not 
possible to know whether, for instance, these self‐report 
measures of MD are also measuring MD in nonclinical 
samples.
5 |  CONCLUSIONS
Our meta‐analysis demonstrated that the scores on the scales 
to assess MD, for the total scale and for the subscales, present 
acceptable reliability (internal consistency and test–retest) for 
research purposes, except for the PU subscale of the MDI. In 
addition, our findings showed that the tests examined present 
acceptable reliability (internal consistency and test–retest) for 
making clinical decisions in a professional context, except for 
the ACQ scores and the following subscales: the IR subscale 
of the MASS, and the PU and ED subscales of the MDI. In 
general, in terms of reliability, the MASS should be the scale 
of choice to assess MD. However, researchers and practition-
ers must take into account that high reliability (e.g., alpha) is 
not a guarantee that a test designed to measure a psychologi-
cal construct (e.g., MD) actually measures the construct in 
question across samples and contexts (Fried & Flake, 2018; 
Hussey & Hughes, 2018). Test scores can be perfectly re-
liable (error‐free), but they may not be valid if they do not 
measure the attribute in question. Thus, as Flake et al. (2017) 
pointed out, when researchers use a test in a study, they 
should provide evidence of construct validation (substan-
tive and structural validation) before they draw conclusions 
from the results of primary analyses. That is, they should en-
sure that the MASS measures MD in their study, and so they 
should carry out sample‐specific analyses to offer evidence 
of its structural validity (e.g., confirmatory factor analysis).
Finally, although the reliability induction rate found 
in our study is much lower than what was found in pre-
vious meta‐analytic research, it is also worth noting that 
reliability induction is an erroneous practice that must be 
eradicated. Researchers need to ensure that their psycho-
logical tests provide accurate information about the psy-
chological constructs they evaluate before interpreting 
their results; otherwise, they can make errors in the estima-
tion of the measures used.
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